KR20250006933A - 아데노 연관 바이러스의 접합 - Google Patents

아데노 연관 바이러스의 접합 Download PDF

Info

Publication number
KR20250006933A
KR20250006933A KR1020247038820A KR20247038820A KR20250006933A KR 20250006933 A KR20250006933 A KR 20250006933A KR 1020247038820 A KR1020247038820 A KR 1020247038820A KR 20247038820 A KR20247038820 A KR 20247038820A KR 20250006933 A KR20250006933 A KR 20250006933A
Authority
KR
South Korea
Prior art keywords
seq
aav
region
sortase
capsid protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247038820A
Other languages
English (en)
Korean (ko)
Inventor
엘스 헨카에르츠
벤자민 모예어르트
티네 브라운스
Original Assignee
타비라 테라퓨틱스 비브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 타비라 테라퓨틱스 비브이 filed Critical 타비라 테라퓨틱스 비브이
Publication of KR20250006933A publication Critical patent/KR20250006933A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14145—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C12N2810/855—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from receptors; from cell surface antigens; from cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C12N2810/859—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1020247038820A 2022-04-28 2023-04-28 아데노 연관 바이러스의 접합 Pending KR20250006933A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22170610.4 2022-04-28
EP22170610 2022-04-28
PCT/EP2023/061210 WO2023209137A1 (en) 2022-04-28 2023-04-28 Conjugation of adeno-associated viruses

Publications (1)

Publication Number Publication Date
KR20250006933A true KR20250006933A (ko) 2025-01-13

Family

ID=81392570

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247038820A Pending KR20250006933A (ko) 2022-04-28 2023-04-28 아데노 연관 바이러스의 접합

Country Status (6)

Country Link
US (1) US20250188489A1 (https=)
EP (1) EP4514985A1 (https=)
JP (1) JP2025514348A (https=)
KR (1) KR20250006933A (https=)
CN (1) CN119095973A (https=)
WO (1) WO2023209137A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025021772A1 (en) * 2023-07-21 2025-01-30 Borea Therapeutics S.R.L. Chemogenetic surface modified viral particles
WO2026037757A1 (en) * 2024-08-13 2026-02-19 F. Hoffmann-La Roche Ag Modified aav particles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018191750A2 (en) * 2017-04-14 2018-10-18 The Broad Institute Inc. Novel delivery of large payloads

Also Published As

Publication number Publication date
EP4514985A1 (en) 2025-03-05
CN119095973A (zh) 2024-12-06
WO2023209137A1 (en) 2023-11-02
JP2025514348A (ja) 2025-05-02
US20250188489A1 (en) 2025-06-12

Similar Documents

Publication Publication Date Title
US12404526B2 (en) Enhancing agents for improved cell transfection and/or rAAV vector production
CN101511373B (zh) 用于基因治疗的修饰的因子ⅷ和因子ⅸ基因和载体
US20250376697A1 (en) Modular system for gene and protein delivery based on aav
KR20220012249A (ko) 조작 aav
JP2024514956A (ja) 組織標的化された改変ａａｖカプシドおよびその使用方法
US20240390517A1 (en) Aav8 capsid variants with enhanced liver targeting
CN112566923A (zh) 合成嗜肝性腺相关病毒衣壳及其用途
CN114008069A (zh) 外来体和aav的组合物
JP2017510264A (ja) 昆虫細胞で産生される、さらに改善されたａａｖベクター
CN116096377A (zh) 跨物种相容的腺相关病毒组合物及其使用方法
US20230049066A1 (en) Novel aav3b variants that target human hepatocytes in the liver of humanized mice
US20250188489A1 (en) Conjugation of adeno-associated viruses
CN116249771A (zh) 改进的腺相关病毒基因治疗载体
CN111718418B (zh) 一种增强基因编辑的融合蛋白及其应用
Hoffmann et al. Unlocking precision gene therapy: harnessing AAV tropism with nanobody swapping at capsid hotspots
US20230175013A1 (en) Controlled modification of adeno-associated virus (aav) for enhanced gene therapy
TW202325720A (zh) 經修飾aav蛋白殼及載體
US20260041792A1 (en) Novel aav3b capsid variants with enhanced hepatocyte tropism
US20240124892A1 (en) Adeno-associated viruses and methods and materials for making and using adeno-associated viruses
WO2024050547A2 (en) Compact bidirectional promoters for gene expression
AU2013254897B2 (en) Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV in insect cells
RU2802520C2 (ru) УСИЛИВАЮЩИЕ АГЕНТЫ ДЛЯ ПОВЫШЕНИЯ ТРАНСФЕКЦИИ КЛЕТОК И/ИЛИ ПРОДУКЦИИ ВЕКТОРА rAAV
CA3092451C (en) A modular system for gene and protein delivery based on aav
WO2026037757A1 (en) Modified aav particles
HK40106196A (zh) 在昆虫细胞中制备腺相关病毒载体

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20241121

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application